Oncology Diagnostics Panel Session
Part 3 of our latest series discusses how the emergence of Immuno-Oncology has impacted the Oncology Diagnostics landscape.
- Shailesh Maingi – Founder and CEO, Kineticos
- Eric Mayer – CEO, EDP Biotech
- Sandra Dunn – CEO, Phoenix Molecular
- Brian Kelly – Global Director, Diagnostic Partnering, Thermo Fisher
Subscribe to Kineticos to receive weekly emails containing insightful content.